| Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons |
| Author(s): Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4) |
| Affiliations(s): 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan
3) Health and Value, Pfizer Japan Inc., Tokyo, Japan
4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): The Journal of Dermatology
|
| Document Type(s): Article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Dermatology, Mental health,
2022 |
|
L:
A: |
English
Patient questionnaire, Quality of life, Survey research, |
|
 |
| |
| |
| Direct costs associated with lupus nephritis management in the Private Healthcare System in Brazil: an expert panel perspective |
| Author(s): Danielle O. Silva (1), Nathalie David (1), Bruce Y. Kano (2), Diego Kashiura (2), Odirlei A. Monticielo (3), André Hayata (4), Mariana R. Gazzotti (1), Graziela Bernardino (1) |
| Affiliations(s): 1: GSK, Rio de Janeiro, RJ, Brasil; 2: IQVIA Real World Insights, São Paulo, SP, Brazil; 3: Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; 4: Centro de Reumatologia Avançada, São Paulo, SP, Brazil |
Publication(s): J Bras Econ Saúde 2022;14(3):232-46
|
| Document Type(s): Article, |
| Countries: Brazil, |
| Click here for the abstract |
C:
Y: |
Dermatology, Health economics,
2022 |
|
L:
A: |
English
Cost analysis, |
|
|
| |
| |
| Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study |
| Author(s): Farah Toron 1, Maureen P Neary 2, Timothy W Smith 3, David Gruben 4, William Romero 5, Amy Cha 3, Keyur Patel 1, Simona Z Vasileva 6, Mahreen Ameen 7 |
| Affiliations(s): 1Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK.
2Inflammation & Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA.
3Inflammation & Immunology, Pfizer Inc, New York, New York, USA.
4Global Biometrics and Data Management (Statistics), Pfizer Inc, Groton, Connecticut, USA.
5Inflammation & Immunology, Pfizer Ltd, Surrey, UK.
6Health Economics and Outcomes Research, Real World Solutions, IQVIA, 210 Pentonville Road, London, N1 9JY, UK. simona.vasileva@iqvia.com.
7Royal Free London National Health Services Foundation Trust, London, UK. |
Publication(s): PMID: 33846907 PMCID: PMC8163940 DOI: 10.1007/s13555-021-00519-7
|
| Document Type(s): Article, |
| Countries: UK, |
| Click here for the abstract |
C:
Y: |
Dermatology, Drug Utlization Study, Methodology,
2021 |
|
L:
A: |
English
direct to patient research, direct-to-patient research, Economic evaluation, Population Based Study, Retrospective database analysis, |
|
|
| |
| |
| Dose increase beyond labelled dose of biologics is associated with incremental pharmacy costs: results from a real-world study in the UK
|
| Author(s): Anthony Bewley 1, Cristiana Miglio 2, Haijun Tian 3, Isabelle Gilloteau 4, Joannah Whitehead 5, Ruben Hermans 2 |
| Affiliations(s): 1a Whipps Cross University Hospital , London , UK.
2b IQVIA , London , UK.
3c Novartis Pharmaceuticals Corporation , East Hanover , NJ , USA.
4d Novartis Pharma AG , Novartis Campus , Basel , Switzerland.
5e Novartis UK Pharmaceuticals Ltd , Frimley, Camberley , UK. |
Publication(s): J Dermatolog Treat
. 2019 Jun;30(4):376-382. doi: 10.1080/09546634.2018.1524820. Epub 2018 Nov 19.
|
| Document Type(s): Article, |
| Countries: UK, |
| Click here for the abstract |
C:
Y: |
Dermatology, Guidelines, Health status & patient reported outcomes, Infectious disease, Infectious disease,
2019 |
|
L:
A: |
English
Burden of illness, Clinical setting: Primary care, direct-to-patient research, Observational study, |
|
|
| |
| |
| DERMATOLOGY AS AN EXAMPLE Originator and Generic Market Access Pretection Strategies in Germany Using Dermatology as an Example |
| Author(s): Greiner RA, Antoni B, Batscheider A, Bonduelle D Roxlau T, Stratil AS |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: Germany, |
C:
Y: |
Dermatology, Health economics,
2018 |
|
L:
A: |
English
Market impact, |
|
|
| |
| |
| Cost-Effectiveness Analysis of Brodalumab in Moderate-to-Severe Plaque Psoriasis in Canada |
| Author(s): Xue, W. 1, Gray, E. 1, Khoudigian-Sinani, S. 2, Barbeau, M. 3, Frieder, D. 3 |
| Affiliations(s): 1 IQVIA, London, UK,
2 IQVIA Mississauga, ON, Canada,
3 Valeant Canada LP, Laval QC, Canada |
Publication(s): ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA
|
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Dermatology,
2018 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
| Efficacy of Brodalumab in the Treatment of Moderate-to-Severe Psoriasis: A Network Meta-Analysis |
| Author(s): Xue, W. 1, Saharia, P. 2, Gray, E. 1, Khoudigian-Sinani, S. 3, Barbeau, M. 4, Frieder, D. 4 |
| Affiliations(s): 1. IQVIA, London, UK,
2. IQVIA Gurugram, India,
3. IQVIA Mississauga, ON, Canada,
4. Valeant Canada LP, Laval QC, Canada |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Dermatology,
2018 |
|
L:
A: |
English
Meta analysis, |
|
|
| |
| |
| Treatment Patterns, Adherence, and Persistence among Psoriasis Patients Treated with Biologics in a Real-World Setting, Overall and by Disease Severity |
| Author(s): Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Zbrozek A, Araujo AB |
| Affiliations(s): Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: cBrigham and Women’s |
Publication(s): Journal of Dermatological Treatment
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Dermatology, Drug Utlization Study, Patient Registries & Real-World Study Methods,
2018 |
|
L:
A: |
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, |
|
|
| |
| |
| Healthcare Resource Utilization and Costs among Psoriasis Patients Treated with Biologics, Overall and by Disease Severity |
| Author(s): Murage MJ, Anderson A, Oliveria SA, Casso D, Ojeh CK, Muram TM, Merola JF, Araujo AB |
| Affiliations(s): Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Casso D: IQVIA; Ojeh CK: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Merola JF: Harvard Medical School; Araujo AB: Eli Lilly and Company |
Publication(s): Journal of Medical Economics
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Dermatology, Patient Registries & Real-World Study Methods, Pricing and reimbursement,
2018 |
|
L:
A: |
English
Cost analysis, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, |
|
|
| |
| |
| Adherence and Persistence to Biologics Among Psoriasis Patients, Overall and by Disease Severity |
| Author(s): Murage MJ, Anderson A, Oliveria SA, Al Sawah S, Casso D, Malatestinic WN, Tanaka Y, Muram TM, Ojeh CK, Zbrozek A, Araujo AB |
| Affiliations(s): Murage MJ: Eli Lilly and Company; Anderson A: IQVIA; Oliveria SA: IQVIA; Al Sawah S: Eli Lilly and Company; Casso D: IQVIA; Malatestinic WN: Eli Lilly and Company; Tanaka Y: Eli Lilly and Company; Muram TM: Eli Lilly and Company; Ojeh CK: Eli Lilly and Company; Zbrozek A: Eli Lilly and Company, Araujo AB: Eli Lilly and Company |
Publication(s): 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
|
| Document Type(s): Abstract, |
| Countries: USA, |
C:
Y: |
Database Validity and methodology, Dermatology, Drug Utlization Study, Urology,
2018 |
|
L:
A: |
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, |
|
|
| |
| |
 1 of 11 
|
